Published in
Elsevier, Annals of Oncology, 9(31), p. 1186-1197, 2020
DOI: 10.1016/j.annonc.2020.06.006
Links
Tools
HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies
Journal article published in 2020 by
D. J. Khalaf,
I. M. Aragón,
M. Annala,
S. Taavitsainen,
R. and Taavitsainen S. Lozano,
D. Lorente 
,
N. Romero-Laorden ,
D. L. and Romero-Laorden N. Finch,
J. Vergidis,
Y. Cendón ,
C. Oja,
M. I. Pacheco,
M. Zulfiqar,
M. E. Gleave,
A. W. Wyatt
and other authors.
,
N. Romero-Laorden ,
D. L. and Romero-Laorden N. Finch,
J. Vergidis,
Y. Cendón ,
C. Oja,
M. I. Pacheco,
M. Zulfiqar,
M. E. Gleave,
A. W. Wyatt
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 